Clinical trial
Bariatric Dose-ranging Study With Dexmedetomidine
NCT00363935 · University of Texas Southwestern Medical Center, Other · Withdrawn
Key facts
| NCT number | NCT00363935 |
|---|---|
| Title | Bariatric Dose-ranging Study With Dexmedetomidine |
| Official title | A Randomized, Double-blind, Controlled Study of Dexmedetomidine (Precedex) Infusion for Improving Control of Acute Autonomic Response During Laparoscopic Bariatric Surgery |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Abdominal Surgery Patients |
| Intervention type | Drug |
| Interventions | Dexmedetomidine |
| Enrollment | 0 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Aug 15, 2006 |
| Last update posted | Jan 16, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: